conclusions we assessed polysomnographic parameters of ahi, odi, laso2 and mean nocturnal spo2 levels, which are especially important in the association between nafld and osas. we think that it is necessary to be attentive regarding nafld development and progression in patients with osa whose nocturnal hypoxia is severe. patients and methods in this study, between december 2011 and december 201...

The rapidly increasing prevalence of childhood obesity and its associated co-morbidities such as hypertriglyceridemia, hyper-insulinemia, hypertension, early atherosclerosis, metabolic syndrome, and non-alcoholic fatty liver disease are major public health concerns in many countries. Therefore the trends in child and adolescent obesity should be closely monitored over time, as in the near futur...

INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the developed world (1). NAFLD refers to a spectrum of liver disorders occurring due to abnormal fat deposition in the liver, which ranges in severity from simple hepatic steatosis with no inflammation, to steatohepatitis (NASH) which can progress to liver cirrhosis. The diagnosis of NAFL...

Edgard Delvin CHU Sainte-Justine Research Center, 3175 Côte Ste-Catherine, Montreal, Quebec, Canada, H3T 1C5 e-mail: delvineasympatico.ca. Tel: (450) 681-1715 Summary: The rapidly increasing prevalence of childhood obesity and its associated co-morbidities such as hypertriglyceridemia, hyper-insulinemia, hypertension, early atherosclerosis, metabolic syndrome, and non-alcoholic fatty liver dise...

Non-alcoholic fatty liver disease (NAFLD) in children has become the most common liver disease influencing adolescent health and one of the most influencing chronic liver diseases among children in Chinese wealthy families, particularly in coastal regions. However, the medicine available for the treatment of NAFLD is deficient. In order to solve this problem, our team studied the activated carb...

Non-alcoholic fatty liver disease (NAFLD) is now a major risk factor for death among patients with disease. Currently, drugs that primarily affect surrogate markers of NAFLD are available. However, none these showed significant effect on the course steatohepatitis and fibrogenesis. The search most relevant lifestyle modification programs still priority in comprehensive treatment. A clinical cas...

AIM To investigated in non-alcoholic-fatty-liver-disease (NAFLD), with ultrasound (US)-detected fatty liver, and in a group of non-alcoholic and otherwise healthy subjects, relationship of neglected features of lifestyle with NAFLD and obesity. METHODS Five hundred and thirty-two NAFLD and 667 non-NAFLD healthy subjects, age 21-60 years were studied. Severity of liver steatosis was assessed b...

Non-alcoholic fatty liver disease (NAFLD), the liver manifestation of the metabolic syndrome, is now considered to be the commonest liver problem in the western world. This apparent 'epidemic', coupled with an accumulating body of evidence that a significant proportion of patients with NAFLD can progress to cirrhosis, liver failure and hepatocellular carcinoma (HCC), has--perhaps not surprising...